RE: SP rerate - worst case scenario21 Jul 2025 10:25
So Stu...nothing has changed...no further information has been released. But suddenly your research suggests an "announcement sooner or later confirming, definitive early efficacy within those treated." You have been attacking Haywain consistently for his view that that is what has been strongly suggested by the early paediatric expansion approval by the FDA amongst other things. Haywain who has demonstrated consistently that he is as close as a scientist can be to being in this industry, in this sector, in this type of drug development program. He has explained clearly multiple times of why he has the view that HEMO's CAR-T could be successful.
That's compared to you, the fork tongued trader who has done his bit to drag down the share price and is now buying back in? You have bent yourself in knots trying to pretend you're sincere and to shift focus away from educated views. I'm sure you'll try again now...that is your nature.
The difference between the rampers and you is that you are collectively trying to manipulate views to achieve your trading goals and don't give a jot about the cost to anyone else or the actual outcome for HEMO. You can't even pretend to care about the patients.
The rampers believe the science, have believed the science for a while...have been naive on the finances and timescales...but collectively they are willing HEMO to do well for the benefit of everyone, including patients. You can pretend to dress up cynicism as a counter-voice amongst the rampers but you have zero credibility - your motives are clear to anyone who looks at this page for more than a minute. You're betting people have shorter attention spans and you can get away with it, but that's been figured out and why many of the rampers will push you down the page again and again